EXPANDING THE USE OF REAL-WORLD DATA TO ANSWER CLINICAL PHARMACOLOGY QUESTIONS: DEVELOPMENT OF A USER-FRIENDLY DASHBOARD TO ASSESS PREVALENCE OF ORGAN IMPAIRMENT IN PATIENTS IN THE REAL-WORLD SETTING

被引:0
|
作者
Vora, B. [1 ]
Velasquez, E. [1 ]
Zhang, R. [1 ]
Igras, K. [2 ]
James, S. [1 ]
机构
[1] Genentech Inc, San Francisco, CA USA
[2] 7N Spzoo, Warsaw, Poland
关键词
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
PII-033
引用
收藏
页码:S58 / S58
页数:1
相关论文
共 50 条
  • [41] DO ATHEROSCLEROTIC EVENTS CHANGE LIPID LOWERING THERAPY USE IN CLINICAL PRACTICE? - THE ANSWER WITH REAL-WORLD DATA
    Seabra, D.
    Araujo, F.
    Afonso-Silva, M.
    Grangeia, D.
    Taveira-Gomes, T.
    Gavina, C.
    ATHEROSCLEROSIS, 2022, 355 : E75 - E75
  • [42] Clinical and economic burden of organ damage among patients with systemic lupus erythematosus in a real-world setting in Germany
    Schultze, Michael
    Garal-Pantaler, Elena
    Pignot, Marc
    Levy, Roger A.
    Carnarius, Heike
    Schneider, Matthias
    Gairy, Kerry
    BMC RHEUMATOLOGY, 2024, 8 (01)
  • [43] Use of Alemtuzumab in a real-world clinical setting: The experience from San Raffaele Hospital
    Zanetta, Chiara
    Nozzolillo, Agostino
    Guerrieri, Simone
    Esposito, Federica
    Romeo, Marzia
    Preziosa, Paolo
    Genchi, Angela
    Filippi, Massimo
    Moiola, Lucia
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2021, 429
  • [44] Interpreting clinical trial data in multiple myeloma: translating findings to the real-world setting
    Paul G. Richardson
    Jesus F. San Miguel
    Philippe Moreau
    Roman Hajek
    Meletios A. Dimopoulos
    Jacob P. Laubach
    Antonio Palumbo
    Katarina Luptakova
    Dorothy Romanus
    Tomas Skacel
    Shaji K. Kumar
    Kenneth C. Anderson
    Blood Cancer Journal, 8
  • [45] Malaysian real-world data to describe progressive pulmonary fibrosis (PPF) in a clinical setting
    Aflah, Syazatul Syakirin Sirol
    Sulaiman, Noraishah
    Lilah, Mohd Syahin Shahira
    Khoo, Ming Yi
    Leow, Wooi Leong
    EUROPEAN RESPIRATORY JOURNAL, 2023, 62
  • [46] Interpreting clinical trial data in multiple myeloma: translating findings to the real-world setting
    Richardson, Paul G.
    San Miguel, Jesus F.
    Moreau, Philippe
    Hajek, Roman
    Dimopoulos, Meletios A.
    Laubach, Jacob P.
    Palumbo, Antonio
    Luptakova, Katarina
    Romanus, Dorothy
    Skacel, Tomas
    Kumar, Shaji K.
    Anderson, Kenneth C.
    BLOOD CANCER JOURNAL, 2018, 8
  • [47] The Use of Real-World Evidence and Data in Clinical Research and Postapproval Safety Studies
    Mary Jo Lamberti
    Wayne Kubick
    Josephine Awatin
    John McCormick
    James Carroll
    Ken Getz
    Therapeutic Innovation & Regulatory Science, 2018, 52 : 778 - 783
  • [48] The Use of Real-World Evidence and Data in Clinical Research and Postapproval Safety Studies
    Lamberti, Mary Jo
    Kubick, Wayne
    Awatin, Josephine
    McCormick, John
    Carroll, James
    Getz, Ken
    THERAPEUTIC INNOVATION & REGULATORY SCIENCE, 2018, 52 (06) : 778 - 783
  • [49] Demographic clinical trial diversity assessment methods: Use of real-world data
    Chen, Hua
    Emechebe, Nnadozie
    Karve, Sudeep
    Raskin, Leon
    Leal, Jailene
    Cheng, Ning
    Sebby, Wendy
    Ribeiro, Kim
    Crawford, Samuel
    CONTEMPORARY CLINICAL TRIALS COMMUNICATIONS, 2025, 44
  • [50] Real-world data on the clinical use of angiogenic factors in pregnancies with placental dysfunction
    Dathan-Stumpf, Anne
    Czarnowsky, Victoria
    Hein, Vicky
    Andraczek, Theresa
    Stepan, Holger
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2022, 226 (02) : S1037 - +